GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
G

Genovis GENO.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

21.00

-0.47%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Analyst ratings

8 analysts, 1 Feb 2026. The analysts' own views, not ours.

  • 3Strong buy
  • 4Buy
  • 1Hold
  • 0Sell
  • 0Strong sell

Price targets

Brokers' own targets, 1 Feb 2026. Not our view.

Average target 35.70

Low
29.29
Average
35.70
Median
30.60
High
48.30

Forecasts

Analyst averages for the fiscal years ahead

FY2026FY2027FY2028FY2029FY2030
RevenueSEK 141.7mSEK 178.6mSEK 211.9mSEK 269.0mSEK 313.0m
Revenue, highestSEK 146.1mSEK 186.0mSEK 230.7mSEK 282.6mSEK 328.8m
Revenue, lowestSEK 137.3mSEK 171.1mSEK 193.2mSEK 255.4mSEK 297.2m
Earnings per share0.290.540.750.971.22
Earnings per share, highest0.350.580.761.031.30
Earnings per share, lowest0.220.500.740.911.14
Analysts22211

Earnings against forecasts

Earnings per share by fiscal quarter

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Forecast0.060.070.170.100.080.100.060.09
Reported0.020.070.100.120.080.050.070.21
Difference-66.6%-13.3%-40.6%+17.6%-2.0%-48.4%+14.4%+142.2%

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

5 / 10

Revenue growth 25.5% a year over 10 years. Return on equity 8.7%.

Model fair value

19.41

From earnings 19.41, from revenue 27.80.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.